TikTok owner ByteDance and Fosun Health backed the mental health service provider’s $31m series C round.

Q&A with Jay Crone and Jon Wolkin, directors, Telus Ventures

Baidu’s corporate venturing arm has re-invested in the immunotherapy developer to help commercialise its pipeline.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Senior care provider Homage has added series C financing to its coffers.

Versanis Bio secured $70 to commercialise a treatment licensed from Novartis, while Salesforce, Intel, Orange, Nike and Alphabet all celebrated exits.

Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms and Dentsu Ventures are all shareholders in the diagnostic testing technology developer.

The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.

Alexandria Venture Investments is among the investors supporting the immunotherapy developer focused on cancer, autoimmune and infectious diseases.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.